Clinical Trial Update: Guanfacine Clinical Trial for Smoking Cessation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessment of guanfacine for smoking cessation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• Guanfacine (guanfacine)

Snippet

Sponsor: Yale University | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2021-12-29